You haven't searched anything yet.
Company
Walden Biosciences’ mission is to transform the treatment of kidney disease by reversing its
progression and enabling patients to resume their normal lives. Walden is a private, Series B,
venture-backed biopharmaceutical company developing first-in-class, highly targeted,
disease-modifying therapies for individuals living with kidney disease.
Walden’s most advanced programs address two novel targets: soluble urokinase plasminogen activating receptor (suPAR) and dynamin. Modulation of both of these targets is expected to provide a significant improvement for multiple kidney diseases. As a member of the Walden Team, you will have an important role in helping to bring this mission to life.
Walden has state of the art laboratory facilities located in the heart of Kendall Square in
Cambridge, Massachusetts. For more information, please visit www.waldenbiosciences.com
Job Summary
The Head of Clinical Development will design, lead the execution, and ensure the completion of
clinical studies of Walden’s disease modifying agents addressing chronic kidney disease (CKD) over the products lifecycles. The successful candidate will have experience and have demonstrated leadership in industrial clinical development. The successful candidate will collaborate with the leaders of the regulatory and medical affairs functions at Walden as well as with external CRO(s). The Head of Clinical Development will report directly to the Chief Executive Officer and have frequent direct interaction with all levels of the Walden team and Board of Directors, external stakeholders, and regulatory authorities.
Responsibilities
Education, experience, and competencies
Full Time
$205k-263k (estimate)
01/27/2024
06/23/2024
waldenbiosciences.com
Cambridge, MA
<25